Calidi Biotherapeutics(简称CLDI)宣布与Avance Clinical建立合作伙伴关系,双方将共同推进在澳大利亚的监管审批流程,并加速启动Cld-401的临床试验。这一合作有望为Calidi Biotherapeutics的临床开发计划提供重要支持,助力其加快创新疗法的落地进程。
Calidi Biotherapeutics(简称CLDI)宣布与Avance Clinical建立合作伙伴关系,双方将共同推进在澳大利亚的监管审批流程,并加速启动Cld-401的临床试验。这一合作有望为Calidi Biotherapeutics的临床开发计划提供重要支持,助力其加快创新疗法的落地进程。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.